INM
INM operates in Health Care Equipment.
INM (INM) - Net Assets
Latest net assets as of June 2024: zł3.94 Million PLN
Based on the latest financial reports, INM (INM) has net assets worth zł3.94 Million PLN as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł38.69 Million) and total liabilities (zł34.75 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | zł3.94 Million |
| % of Total Assets | 10.18% |
| Annual Growth Rate | -15.6% |
| 5-Year Change | -53.12% |
| 10-Year Change | N/A |
| Growth Volatility | 72.3 |
INM - Net Assets Trend (2018–2023)
This chart illustrates how INM's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for INM (2018–2023)
The table below shows the annual net assets of INM from 2018 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | zł5.93 Million | -24.16% |
| 2022-12-31 | zł7.82 Million | -73.91% |
| 2021-12-31 | zł29.97 Million | -2.20% |
| 2020-12-31 | zł30.65 Million | +142.25% |
| 2019-12-31 | zł12.65 Million | -8.63% |
| 2018-12-31 | zł13.85 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to INM's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2636564111.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | zł34.12 Million | 575.25% |
| Total Equity | zł5.93 Million | 100.00% |
INM Competitors by Market Cap
The table below lists competitors of INM ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Present24 SA
WAR:P24
|
$281.73 |
|
BATERO GOLD (68B.SG)
STU:68B
|
$281.78 |
|
BEIJING JINGKELNG-H
MU:G2M
|
$281.84 |
|
Redefy Corporation
PINK:RDCO
|
$282.27 |
|
MEDIGENE N (MDG1.SG)
STU:MDG1
|
$280.86 |
|
PCI BIOTECH HLD
BE:4QG
|
$280.81 |
|
PRN
WAR:PRN
|
$280.75 |
|
HYDROTEC GES.F.WASSERT
HM:HYW
|
$280.50 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in INM's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 7,819,694 to 5,930,529, a change of -1,889,165 (-24.2%).
- Net loss of 1,889,165 reduced equity.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | zł-1.89 Million | -31.85% |
| Other Changes | zł-0.00 | -0.0% |
| Total Change | zł- | -24.16% |
Book Value vs Market Value Analysis
This analysis compares INM's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.43x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.98x to 4.43x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | zł0.13 | zł0.13 | x |
| 2021-12-31 | zł0.13 | zł0.13 | x |
| 2022-12-31 | zł0.04 | zł0.13 | x |
| 2023-12-31 | zł0.03 | zł0.13 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently INM utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -31.85%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -629721.65%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 7.24x
- Recent ROE (-31.85%) is above the historical average (-55.59%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | -8.62% | 0.00% | 0.00x | 1.01x | zł-2.58 Million |
| 2019 | -6.09% | -1879.20% | 0.00x | 1.05x | zł-2.04 Million |
| 2020 | -1.40% | -8231.73% | 0.00x | 1.05x | zł-3.49 Million |
| 2021 | -2.25% | -6450.42% | 0.00x | 1.46x | zł-3.67 Million |
| 2022 | -283.31% | -544997.32% | 0.00x | 3.88x | zł-22.94 Million |
| 2023 | -31.85% | -629721.65% | 0.00x | 7.24x | zł-2.48 Million |
Industry Comparison
This section compares INM's net assets metrics with peer companies in the Healthcare Equipment & Supplies industry.
Industry Context
- Industry: Healthcare Equipment & Supplies
- Average net assets among peers: $5,427,680
- Average return on equity (ROE) among peers: -79.10%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| INM (INM) | zł3.94 Million | -8.62% | 8.82x | $281.61 |
| Nestmedic S.A. (NST) | $5.43 Million | -79.10% | 1.14x | $1.59K |